Literature DB >> 30012833

Balanced Rac1 activity controls formation and maintenance of neuromuscular acetylcholine receptor clusters.

Yanyang Bai1, Daji Guo1, Xiaoyu Sun1, Genyun Tang2, Tailin Liao3, Yinghui Peng1, Junyu Xu3, Lei Shi4.   

Abstract

Rac1, an important Rho GTPase that regulates the actin cytoskeleton, has long been suggested to participate in acetylcholine receptor (AChR) clustering at the postsynaptic neuromuscular junction. However, how Rac1 is regulated and how it influences AChR clusters have remained unexplored. This study shows that breaking the balance of Rac1 regulation, by either increasing or decreasing its activity, led to impaired formation and maintenance of AChR clusters. By manipulating Rac1 activity at different stages of AChR clustering in cultured myotubes, we show that Rac1 activation was required for the initial formation of AChR clusters, but its persistent activation led to AChR destabilization, and uncontrolled hyperactivation of Rac1 even caused excessive myotube fusion. Both AChR dispersal and myotube fusion induced by Rac1 were dependent on its downstream effector Pak1. Two Rac1 GAPs and six Rac1 GEFs were screened and found to be important for normal AChR clustering. This study reveals that, although general Rac1 activity remains at low levels during terminal differentiation of myotubes and AChR cluster maintenance, tightly regulated Rac1 activity controls normal AChR clustering.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Acetylcholine receptor; Actin; Agrin; Neuromuscular junction; Rac1; Rho GTPase

Mesh:

Substances:

Year:  2018        PMID: 30012833     DOI: 10.1242/jcs.215251

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  Control of CRK-RAC1 activity by the miR-1/206/133 miRNA family is essential for neuromuscular junction function.

Authors:  Ina Klockner; Christian Schutt; Theresa Gerhardt; Thomas Boettger; Thomas Braun
Journal:  Nat Commun       Date:  2022-06-08       Impact factor: 17.694

2.  Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy.

Authors:  Laura H Comley; Rachel A Kline; Alison K Thomson; Victoria Woschitz; Eric Villalón Landeros; Erkan Y Osman; Christian L Lorson; Lyndsay M Murray
Journal:  Hum Mol Genet       Date:  2022-09-10       Impact factor: 5.121

3.  DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies.

Authors:  Andrea L Reid; Yimin Wang; Adrienne Samani; Rylie M Hightower; Michael A Lopez; Shawn R Gilbert; Lara Ianov; David K Crossman; Louis J Dell'Italia; Douglas P Millay; Thomas van Groen; Ganesh V Halade; Matthew S Alexander
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

Review 4.  Spatiotemporal Regulation of Rho GTPases in Neuronal Migration.

Authors:  Zhenyan Xu; Yuewen Chen; Yu Chen
Journal:  Cells       Date:  2019-06-10       Impact factor: 6.600

5.  Two Autism/Dyslexia Linked Variations of DOCK4 Disrupt the Gene Function on Rac1/Rap1 Activation, Neurite Outgrowth, and Synapse Development.

Authors:  Miaoqi Huang; Chunmei Liang; Shengnan Li; Jifeng Zhang; Daji Guo; Bo Zhao; Yuyang Liu; Yinghui Peng; Junyu Xu; Wei Liu; Guoqing Guo; Lei Shi
Journal:  Front Cell Neurosci       Date:  2020-01-15       Impact factor: 5.505

6.  Rac Inhibition Causes Impaired GPVI Signalling in Human Platelets through GPVI Shedding and Reduction in PLCγ2 Phosphorylation.

Authors:  Raluca A I Neagoe; Elizabeth E Gardiner; David Stegner; Bernhard Nieswandt; Steve P Watson; Natalie S Poulter
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

7.  Autism-like social deficit generated by Dock4 deficiency is rescued by restoration of Rac1 activity and NMDA receptor function.

Authors:  Daji Guo; Yinghui Peng; Laijian Wang; Xiaoyu Sun; Xiaojun Wang; Chunmei Liang; Xiaoman Yang; Shengnan Li; Junyu Xu; Wen-Cai Ye; Bin Jiang; Lei Shi
Journal:  Mol Psychiatry       Date:  2019-08-06       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.